SGLT2 inhibitors Dapagliflozin have shown positive effects on the human heart.

SGLT2 inhibitors have shown positive effects on the human heart. These medications not only help control blood sugar levels in people with type 2 diabetes but also exhibit cardiovascular benefits. They are associated with a reduction in the risk of heart failure and cardiovascular events. By promoting the excretion of excess glucose in the urine, SGLT2 inhibitors contribute to improved cardiovascular outcomes. Additionally, they may lead to favorable changes in other risk factors, such as blood pressure and weight. However, it's essential to note that individual responses to medications can vary, and these details should be discussed with a healthcare professional.